Clinical Trial Update: Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for the folate-tubulin conjugate EC-1456 in patients with advanced solid tumors, including non-small cell lung carcinoma, has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• EC-1456

Snippet

Sponsor: Endocyte | Conditions: Solid Tumors, Non Small Cell Lung Carcinoma | Phase 1 | Status: COMPLETED